FDCDDQ
ALDX icon

Federation des caisses Desjardins du Quebec’s Aldeyra Therapeutics ALDX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Hold
18,106
– – ﹤0.01% 1996
2026
Q1 		$30.6K Buy
18,106
+5,919
+49% +$25.9K ﹤0.01% 1994
2025
Q4 		$63.1K Buy
12,187
+2,500
+26% +$12.8K ﹤0.01% 1764
2025
Q3 		$50.6K Buy
9,687
+2,695
+39% +$14.1K ﹤0.01% 1805
2025
Q2 		$26.8K Hold
6,992
– – ﹤0.01% 1728
2025
Q1 		$40.2K Hold
6,992
– – ﹤0.01% 1529
2024
Q4 		$34.9K Buy
6,992
+592
+9% +$3.04K ﹤0.01% 1510
2024
Q3 		$34.5K Hold
6,400
– – ﹤0.01% 1503
2024
Q2 		$21.2K Buy
6,400
+1,105
+21% +$4.33K ﹤0.01% 1604
2024
Q1 		$17.3K Hold
5,295
– – ﹤0.01% 1680
2023
Q4 		$18.6K Buy
5,295
+750
+17% +$2.31K ﹤0.01% 1596
2023
Q3 		$30.4K Sell
4,545
-6,485
-59% -$48.1K ﹤0.01% 1453
2023
Q2 		$92.5K Hold
11,030
– – ﹤0.01% 1174
2023
Q1 		$110K Buy
11,030
+1,100
+11% +$7.78K ﹤0.01% 1135
2022
Q4 		$69.1K Sell
9,930
-500
-5% -$2.86K ﹤0.01% 1366
2022
Q3 		$55.7K Buy
10,430
+2,150
+26% +$12.9K ﹤0.01% 1483
2022
Q2 		$33K Buy
8,280
+1,600
+24% +$5.5K ﹤0.01% 1626
2022
Q1 		$29.7K Sell
6,680
-4,500
-40% -$17.9K ﹤0.01% 1727
2021
Q4 		$44.7K Hold
11,180
– – ﹤0.01% 1627
2021
Q3 		$98.2K Buy
11,180
+420
+4% +$3.85K ﹤0.01% 1409
2021
Q2 		$122K Sell
10,760
-5,715
-35% -$68.7K ﹤0.01% 1358
2021
Q1 		$196K Buy
16,475
+1,350
+9% +$15.5K ﹤0.01% 1130
2020
Q4 		$104K Buy
15,125
+2,775
+22% +$19.5K ﹤0.01% 1272
2020
Q3 		$91.5K Buy
12,350
+6,500
+111% +$42K ﹤0.01% 1083
2020
Q2 		$24.4K Buy
+5,850
New +$21.4K ﹤0.01% 1396

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ALDX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Aldeyra Therapeutics (ALDX) position steady in Q2 2026 at 18,106 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Federation des caisses Desjardins du Quebec first reported a position in ALDX in Q2 2020 and has held it in 25 quarters since. The position peaked at $196K in Q1 2021. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 18,106 shares of Aldeyra Therapeutics worth $38.6K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Aldeyra Therapeutics share count unchanged in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1996 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Aldeyra Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Federation des caisses Desjardins du Quebec's Aldeyra Therapeutics position peaked at $196K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.